Elisabeth ("Lis") Leiderman, M.D.
Board Member
Autolus Therapeutics plc (AUTL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Elisabeth ("Lis") Leiderman, M.D.
Elisabeth ("Lis") Leiderman, M.D. is recorded as Board Member at Autolus Therapeutics plc (AUTL). Autolus Therapeutics plc reported in an 8-K filed December 22, 2023 that Elisabeth ("Lis") Leiderman, M.D. was appointed Class II director, effective December 20, 2023.
“On December 22, 2023, the Company announced that the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Elisabeth ("Lis") Leiderman, M.D. to serve as a Class II director of the Company, effective December 20, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-12-20–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Autolus Therapeutics plc
Other people whose current roles at this company are on record from its filings.
- Michael W. Bonney Chairman, Board Member
- Patrick McIlvenny Chief Accounting Officer
- Rob Dolski Chief Accounting Officer
- Ravi M. Rao Board Member
- Robert (“Bob”) W. Azelby Board Member
- Ryan Richardson Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.